Back

Impact of serum uric acid on secondary prevention after percutaneous coronary intervention

30 August 2016 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 7 - Predicting outcomes in cardiac vascular disease Primary cardiovascular prevention: interventions and outcomes ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Ichiro Matsumoto

KKR Takamatsu Hospital, Takamatsu (Japan)

17 More presentations in this session

Presentation thumbnail
Mr B. Sahle (Victoria, AU)
Abstract
Presentation thumbnail
Doctor J. Alvarez-Garcia (Madrid, ES)
Abstract Slides
Presentation thumbnail
Professor E. Vellone (Rome, IT)
Abstract Slides
Presentation thumbnail
Doctor A. Simoes (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Professor P. Mitrovic (Belgrade, RS)
Abstract Slides

Access the full session

Session thumbnail
Poster session 7 - Predicting outcomes in cardiac vascular disease

The Event

Event poster

ESC Congress 2016

30 August 2016 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Hyperuricaemia: nationwide study in st-elevation myocardial infarction patients
15 March 2025
thumbnail
Webinar
Percutaneous interventions in patients with coronary artery disease and specific clinical conditions - IC Core Curriculum 6
9 November 2022
thumbnail
Congress Presentation
Sacubitril/Allisartan in hyperuricemia
31 August 2025
thumbnail
Congress Presentation
Risk factors control, remnant cholesterol, recurrent events and risk in patients with coronary heart disease. Our experiences
4 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources